Dataset Information

Current status and future development of cell transplantation therapy for periodontal tissue regeneration.

ABSTRACT: It has been shown that stem cell transplantation can regenerate periodontal tissue, and several clinical trials involving transplantation of stem cells into human patients have already begun or are in preparation. However, stem cell transplantation therapy is a new technology, and the events following transplantation are poorly understood. Several studies have reported side effects and potential risks associated with stem cell transplantation therapy. To protect patients from such risks, governments have placed regulations on stem cell transplantation therapies. It is important for the clinicians to understand the relevant risks and governmental regulations. This paper describes the ongoing clinical studies, basic research, risks, and governmental controls related to stem cell transplantation therapy. Then, one clinical study is introduced as an example of a government-approved periodontal cell transplantation therapy.

SUBMITTER: Yoshida T

PROVIDER: S-EPMC3272354 | biostudies-other | 2012

REPOSITORIES: biostudies-other

ACCESS DATA

Publications

Current status and future development of cell transplantation therapy for periodontal tissue regeneration.

Yoshida Toshiyuki T Washio Kaoru K Iwata Takanori T Okano Teruo T Ishikawa Isao I

International journal of dentistry 20120116

It has been shown that stem cell transplantation can regenerate periodontal tissue, and several clinical trials involving transplantation of stem cells into human patients have already begun or are in preparation. However, stem cell transplantation therapy is a new technology, and the events following transplantation are poorly understood. Several studies have reported side effects and potential risks associated with stem cell transplantation therapy. To protect patients from such risks, governm ...[more]

PMID: 22315604

Similar Datasets

Project description:The objective of the present study was to evaluate the capacity of a tissue-engineered complex of human osteoprotegerin (hOPG)-transfected periodontal ligament stem cells (PDLSCs) seeding on beta-tricalcium phosphate (?-TCP) to regenerate alveolar bone defects in New Zealand rabbits.PDLSCs were isolated from rabbit periodontal ligament tissues and expanded in vitro to enrich PDLSC numbers, and their proliferative activities and differentiation capability were evaluated under specific induction conditions. Lentiviral vector containing hOPG and enhanced green fluorescent protein (EGFP) was constructed by using Gateway technology and transfected into rabbit PDLSCs. The expression of hOPG was determined with quantitative real-time reverse transcription-polymerase chain reaction and Western blot. The PDLSCs with or without engineered hOPG were seeded on ?-TCP scaffolds prior to transplantation. Morphological characterization of cells and materials was done by scanning electron microscope. Twenty rabbits with alveolar bone defects were randomly allocated into four groups and transplanted with ?-TCP, PDLSCs/?-TCP, and hOPG-transfected PDLSCs/?-TCP or were left untreated as a control. Animals were sacrificed 12 weeks after operation for histological observation and histomorphometric analysis.PDLSCs expressed STRO-1 and vementin and favored osteogenesis and adipogenesis in conditioned media. Expressions of hOPG were significantly upregulated after transfection of the lentiviral vector into PDLSCs. PDLSCs attached and spread well on ?-TCP, and there was no significant difference in growth of PDLSCs on ?-TCP between the hOPG transfection group and the non-transfection group. The histological observation and histomorphometric analysis showed that the hOPG-transfected PDLSCs/?-TCP complex exhibited an earlier mineralization and more bone formation inside the scaffold than control, ?-TCP, and PDLSCs/?-TCP complexes. Implantation of hOPG-transfected PDLSCs contributed to new bone formation as determined by EGFP gene expression under circularly polarized light microscopy.The present study demonstrated the feasibility of ?-TCP scaffolds for primary PDLSC culture and expression of hOPG gene in vitro and in vivo, and hOPG-transfected PDLSCs could serve as a potential cell source for periodontal bone regeneration, which may shed light on the potential of systemic hOPG gene therapy in combination with PDLSC tissue engineering as a good candidate in periodontal tissue engineering for alveolar bone regeneration.

Dataset Information

Current status and future development of cell transplantation therapy for periodontal tissue regeneration.

Publications

Current status and future development of cell transplantation therapy for periodontal tissue regeneration.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure